Abstract
Parkinson's disease is a common neurodegenerative syndrome characterized by loss of dopaminergic neurons in the substantia nigra, formation of filamentous intraneuronal inclusions (Lewy bodies) and an extrapyramidal movement disorder. Mutations in the α-synuclein gene are linked to familial Parkinson's disease1,2 and α-synuclein accumulates in Lewy bodies and Lewy neurites3,4,5. Here we express normal and mutant forms of α-synuclein in Drosophila and produce adult-onset loss of dopaminergic neurons, filamentous intraneuronal inclusions containing α-synuclein and locomotor dysfunction. Our Drosophila model thus recapitulates the essential features of the human disorder, and makes possible a powerful genetic approach to Parkinson's disease.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Polymeropoulos, M. H. et al. Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 276, 2045 –2047 (1997).
Krüger, R. et al. Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease. Nature Genet. 18, 106 –108 (1998).
Spillantini, M. G., Schmidt, M. L., Lee, V. M. -Y. & Trojanowski, J. Q. α-Synuclein in Lewy bodies. Nature 388, 839–840 (1997).
Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M. & Goedert, M. α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. Proc. Natl Acad. Sci. USA 95, 6469 –6473 (1998).
Baba, M. et al.Aggregation of α-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am. J. Pathol. 152, 879–884 (1998).
Brand, A. H. & Perrimon, N. Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development 118, 401–415 ( 1993).
Warrick, J. M. et al. Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in Drosophila. Cell 93, 939–949 (1998).
Budnik, V., Martin-Morris, L. & White, K. Perturbed pattern of catecholamine-containing neurons in mutant Drosophila deficient in the enzyme dopa decarboxylase. J. Neurosci. 6, 3682–3691 (1986).
Budnik, V. & White, L. Catecholamine-containing neurons in Drosophila melanogaster: Distribution and development. J. Comp. Neurol. 268, 400–413 ( 1988).
Lundell, M. J. & Hirsh, J. Temporal and spatial development of serotonin and dopamine neurons in the Drosophila CNS. Dev. Biol. 165, 385–396 (1994).
Gibbs, W. R. G. & Lees, A. J. Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 54, 388–396 ( 1991).
Coombe, P. E. & Heisenberg, M. The structural brain mutant Vacuolar medulla of Drosophila melanogaster with specific behavioral defects and cell degeneration in the adult. J. Neurogenet. 3, 135–158 (1986).
Buchanan, R. L. & Benzer, S. Defective glia in the Drosophila brain degeneration mutant drop-dead. Neuron 10, 839–850 ( 1993).
Jellinger, K. A. Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway. Mol. Chem. Neuropathol. 14, 153– 197 (1991).
Vallés, A. M. & White, K. Serotonin-containing neurons in Drosophila melanogaster: Development and distribution. J. Comp. Neurol. 268, 414–428 (1988).
Kuzuhara, S., Mori, H., Izumiyama, N., Yoshimura, M. & Ihara, Y. Lewy bodies are ubiquitinated: a light and electron microscopic immunocytochemical study. Acta Neuropathol. 75, 345–353 (1988).
Dickson, D. W. et al. Diffuse Lewy body disease: light and electron microscopic immunocytochemistry of senile plaques. Acta Neuropathol. 78, 572–584 (1987).
Pollanen, M. S., Dickson, D. W. & Bergeron, C. Pathology and biology of the Lewy body. J. Neuropathol. Exp. Neurol. 52, 183– 191 (1993).
Ganetzky, B. & Flanagan, J. R. On the relationship between senescence and age-related changes in two wild-type strains of Drosophila melanogaster. Exp. Gerontol. 13, 189 –196 (1978).
Le Bourg, E. & Lints, F. A. Hypergravity and aging in Drosophila melanogaster. 4. Climbing activity. Gerontology 38, 59–64 (1992).
Franceschini, N. in Information Processing in the Visual System of Drosophila (ed. Wehner, R.) 75–82 (Springer, Berlin, 1972).
Conway, K. A., Harper, J. D. & Lansbury, P. T. Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease. Nature Med. 4, 1318–1320 (1998).
Narhi, L. et al. Both familial Parkinson's disease mutations accelerate α-synuclein aggregation. J. Biol. Chem. 274, 9843– 9846 (1999).
El-Agnaf, O. M. A. et al. Aggregates from mutant and wild-type α-synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of β-sheet and amyloid-like filaments. FEBS Lett. 440, 71–75 ( 1998).
Ostreova, N. et al. α-synuclein shares physical and functional homology with 14-3-3 proteins. J. Neurosci. 19, 5782–5791 (1999).
Hong, L. et al. The cDNA cloning and ontogeny of mouse α-synuclein. NeuroReport 9, 1239–1243 (1998).
Masliah, E. et al. Dopaminergic loss and inclusion body formation in α-synuclein mice: implications for neurodegenerative disorders. Science 287, 1265–1269 (2000).
Li, H., Chaney, S., Forte, M. & Hirsh, J. Ectopic G-protein expression in dopamine and serotonin neurons blocks cocaine sensitization in Drosophila melanogaster. Curr. Biol. (in the press).
Robinow, S. & White, L. The locus elav of Drosophila melanogaster is expressed in all neurons at all developmental stages. Dev. Biol. 126, 294–303 (1988).
Ellis M., O'Neill, E. & Rubin, G. Expression of Drosophila glass protein and evidence for negative regulation of its activity in non-neuronal cells by another DNA-binding protein. Development 119, 855–865 (1993).
Acknowledgements
We thank J. Hirsh, J. Hardy, M. Farrer and H. Orr for flies and DNAs; J. Hirsh, D. Dickson, M. Frosch, K. Buckley, W. Quinn and D. Morisato for discussions; and H. Shing, L. Trakimas, A. Merola, C. Ridolfi and M. Ericsson for technical assistance. M.B.F. thanks J. Gusella and the American Parkinson Disease Foundation for encouragement. Support was provided by a Howard Hughes Physician Postdoctoral Fellowship and a grant from the N.I.A. to M.B.F, and by a grant from the N.I.H. to W.B.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Feany, M., Bender, W. A Drosophila model of Parkinson's disease. Nature 404, 394–398 (2000). https://doi.org/10.1038/35006074
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/35006074
This article is cited by
-
Chronic trans fatty acid consumption shortens lifespan in male Drosophila melanogaster on a high-sugar and high-fat diet
Biogerontology (2024)
-
Drosophila olfaction as a model system for studying human neurological disorders
Journal of Biosciences (2023)
-
Prion disease modelled in Drosophila
Cell and Tissue Research (2023)
-
Neuroprotective potential of plant derived parenchymal stem cells extract on environmental and genetic models of Parkinson disease through attenuation of oxidative stress and neuroinflammation
Metabolic Brain Disease (2023)
-
Vexed mutations promote degeneration of dopaminergic neurons through excessive activation of the innate immune response
npj Parkinson's Disease (2022)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.